Business Context and Reporting Period
This Form 10-Q covers The Procter & Gamble Company for the quarterly period ended September 30, 1997. The company operates globally across North America, Europe, Middle East, Africa, Asia, and Latin America, with a focus on consumer goods including laundry, tissue, snacks, beauty care, and health care. The filing includes unaudited consolidated financial statements and management commentary.
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Net Sales | $9,355 million | $8,903 million |
| Net Earnings | $1,087 million | $979 million |
| Diluted EPS | $0.73 | $0.65 |
| Operating Income | $1,739 million | $1,547 million |
| Gross Margin | 44.3% | 43.3% |
| Operating Margin | 18.6% | 17.4% |
| Cash from Operations | $1,172 million | $1,443 million |
| Cash and Equivalents (End) | $2,059 million | $2,595 million |
| Total Debt (Current + Long-Term) | $6,772 million | Not explicitly stated for Q1 1996 |
Liquidity: Current assets totaled $10,907 million against current liabilities of $9,822 million as of September 30, 1997.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5% to $9.4 billion, driven by 8% unit volume growth. Currency weakness in Western Europe and Asia offset some volume gains.
- Profitability: Net earnings rose 11% to $1.085 billion. Earnings per share increased 13% to $0.79, aided by a stock repurchase program reducing share count.
- Acquisitions: The July 1997 acquisition of Tambrands contributed 1% to unit volume growth and significantly impacted the feminine protection category.
- Regional Performance:
- North America: Sales up 6%; earnings up 5%.
- Europe, Middle East, Africa: Sales flat due to currency headwinds despite 10% volume growth; earnings up 6%.
- Asia: Sales up 4%; earnings surged 35% due to pricing and volume, despite currency weakness.
- Latin America: Sales up 15%; earnings jumped 112%, including a gain on the sale of a non-strategic brand.
- Cash Flow: Operating cash flow decreased to $1.172 billion from $1.443 billion, primarily due to increased inventory levels and accounts receivable. Investing activities showed a significant outflow of $2.208 billion, largely due to $1.956 billion in acquisitions.
Outlook, Risks, and Unusual Items
- Management Commentary: Management attributes margin improvements to cost control via simplification and standardization. The company continues to invest in new product initiatives and brand development.
- Unusual Items: Latin America earnings included a one-time gain from the sale of a non-strategic brand. The acquisition of Tambrands is a strategic shift in the feminine care segment.
- Risks: Significant exposure to foreign currency fluctuations, particularly in Western Europe and Asia, which negatively impacted sales growth relative to volume. Continued investment in marketing and R&D may pressure short-term margins.
- Corporate Actions: Shareholders approved an increase in authorized common stock and amendments to preferred stock dividend terms. A shareholder proposal to eliminate chlorine use in paper products was defeated.
Investor Verification Checklist
- Verify the sustainability of the 112% earnings growth in Latin America, noting the inclusion of a one-time asset sale gain.
- Monitor the integration progress and financial contribution of the Tambrands acquisition.
- Assess the impact of ongoing currency weakness in Europe and Asia on future revenue targets.
- Review the cash flow trend, specifically the increase in inventory and receivables, to ensure working capital efficiency.
- Confirm the execution of the stock repurchase program and its impact on future EPS dilution.